好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Use of Electrical Impedance Tomography to Assess Pulmonary Function in ALS Patients
Neuromuscular and Clinical Neurophysiology (EMG)
P2 - Poster Session 2 (11:45 AM-12:45 PM)
11-003

To learn if thoracic electrical impedance tomography (EIT) measurements correlate with pulmonary function test (PFT) results in amyotrophic lateral sclerosis (ALS) patients.

ALS is a motor neuron disorder associated with craniobulbar and respiratory muscle dysfunction. Throughout disease course, PFT data play key roles in monitoring clinical status and planning therapeutic interventions. However, the accuracy of PFT results can be limited by factors including fatigue and incomplete lip seal around the spirometer, a common occurrence in the setting of orofacial weakness. It would therefore be helpful to have an objective measure of lung function that is independent of effort and orofacial strength.

Thoracic EIT could help address this need. In thoracic EIT, painless electrical currents are applied through surface electrodes placed circumferentially around the torso. Resultant surface voltages can be used to calculate a mean value (z metric) that reflects impedance changes between maximum inspiration and expiration over time.

With ALS patients wearing an exercise-like chest band with internal electromyography surface electrodes, EIT information was obtained during the performance of standard slow and forced vital capacity evaluations in upright and supine positions. Correlations were calculated between the EIT (z metric) and vital capacity (VC, %predicted) findings.

To date, 8 individuals (5 men, 3 women) with ALS (average ALS functional rating scale-revised score 33) aged 54-79 (average 65) years have been recruited. Clinical orofacial weakness was noted in 37%. Positive correlations between EIT and VC (upright SVC r2 0.43 p=0.0003, FVC r0.46 p=0.0002; supine SVC r2 0.49 p=0.0007, FVC r0.45 p=0.007) were identified in initial analyses.
These early results suggest a moderate relationship between EIT and pulmonary function. Ongoing and future work will better characterize the utility of EIT as a biomarker for pulmonary function in ALS patients with and without orofacial weakness.
Authors/Disclosures
Courtney E. McIlduff, MD (Beth Israel Deaconess Medical Center)
PRESENTER
The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Allaire Doussan (Thayer School of Engineering) No disclosure on file
Irene C. Yator, MD (University of Kentucky) Ms. Yator has nothing to disclose.
Sarah Verga (Beth Israel Deaconess Medical Center) Miss Verga has nothing to disclose.
Soleil Samaan (Beth Israel Deaconess Medical Center) No disclosure on file
Hilda V. Gutierrez, MD (Beth Israel Deaconess Medical Center) Ms. Gutierrez has nothing to disclose.
Ethan Murphy No disclosure on file
Elijah Stommel, MD, FAAN (Dartmouth-Hitchock Med Ctr/Dept of Neuro) Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Sean Levy No disclosure on file
Ryan Halter No disclosure on file
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.